Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-21

Clinical Trial Update: Safety and Efficacy of Immunomodulator Drug Thalidomide in Multi-transfused Thalassemia Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating the safety and efficacy of thalidomide in multi-transfused thalassemia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalidomide (thalidomide)

Snippet

Sponsor: Muhammad Aamir Latif | Conditions: Thalassemia | NA | Status: COMPLETED